Home Dermatology PDF: Update on Drugs & Devices: May – June 2023
- You cannot add another "PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea" to your cart. View cart
Article
PDF: Update on Drugs & Devices: May – June 2023
$1.99
PDF Download: Update on Targeted alkali thermolysis (TAT) technology (Brella™ 3-miniute SweatControl Patch™), Retifanlimab-dlwr for IV infusion (Zynyz™), Spesolimab IV for IV infusion (Spevigo®) and CRISPR-based therapy (NTLA-2002).
Read online:
Update on Drugs & Devices: May – June 2023
Related products
-
Article
PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma
$1.99 Add to cart -
Article
PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses
$1.99 Add to cart -
Article
PDF: Update on Drugs & Devices: September – October 2019
$1.99 Add to cart -
Article
PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea
$1.99 Add to cart
